First in-Human Vaccine Trial for Deadly Nipah Virus Commences with WHO Backing
In a monumental stride towards combating the lethal Nipah virus, Oxford University researchers have embarked on the first human trials for a vaccine designed to thwart this deadly pathogen. Spearheaded by the esteemed Oxford Vaccine Group, the trials signify a critical juncture in the relentless battle against infectious diseases, particularly those with pandemic potential. ChAdOx1 …
First in-Human Vaccine Trial for Deadly Nipah Virus Commences with WHO Backing Read More »









